EARNEST Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-657
Closed -$51.5K 766
2023
Q3
$51.5K Hold
657
﹤0.01% 366
2023
Q2
$57.9K Hold
657
﹤0.01% 339
2023
Q1
$53K Hold
657
﹤0.01% 340
2022
Q4
$51.1K Hold
657
﹤0.01% 346
2022
Q3
$53K Hold
657
﹤0.01% 326
2022
Q2
$59K Hold
657
﹤0.01% 321
2022
Q1
$73K Hold
657
﹤0.01% 313
2021
Q4
$68K Hold
657
﹤0.01% 320
2021
Q3
$82K Hold
657
﹤0.01% 301
2021
Q2
$82K Hold
657
﹤0.01% 300
2021
Q1
$78K Hold
657
﹤0.01% 299
2020
Q4
$77K Hold
657
﹤0.01% 293
2020
Q3
$68K Hold
657
﹤0.01% 292
2020
Q2
$60K Hold
657
﹤0.01% 289
2020
Q1
$59K Hold
657
﹤0.01% 284
2019
Q4
$75K Hold
657
﹤0.01% 284
2019
Q3
$71K Hold
657
﹤0.01% 285
2019
Q2
$64K Hold
657
﹤0.01% 295
2019
Q1
$60K Hold
657
﹤0.01% 295
2018
Q4
$60K Hold
657
﹤0.01% 286
2018
Q3
$65K Hold
657
﹤0.01% 287
2018
Q2
$56K Hold
657
﹤0.01% 300
2018
Q1
$53K Hold
657
﹤0.01% 302
2017
Q4
$53K Buy
+657
New +$52.6K ﹤0.01% 296
2017
Q1
Sell
-705
Closed -$50K 634
2016
Q4
$50K Buy
+705
New +$55.4K ﹤0.01% 282

Other funds holding MDT

EARNEST Partners's MDT Position: Q4 2023 in Review

EARNEST Partners sold out of Medtronic (MDT) in Q4 2023, closing a stake of 657 shares — an estimated $51.5K sold.

EARNEST Partners first reported a position in MDT in Q4 2016 and held it in 25 quarters. The position peaked at $82K in Q3 2021. 2,078 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • EARNEST Partners reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 657 Medtronic shares in Q4 2023, an estimated $51.5K.
  • EARNEST Partners first reported a position in Medtronic in Q4 2016 and held it in 25 quarters.
  • EARNEST Partners's Medtronic position peaked at $82K in Q3 2021.
  • 2,078 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.